New molecular research suggests commercial caviar-derived ingredients are biologically more complex than current ...

Imviva’s ASGCT presentation highlights encouraging clinical responses in SLE. Among 18 evaluable patients with SLE/lupus nephritis (LN) treated with CTA313, with a median follow-up of six months: 50% ...

The modern definition of being uneducated applies not to those who cannot read and write, but to those unable to utilise ...

The Nuffield Council on Bioethics (NCOB) says there is a clear need for guidance on how to conduct ethical research using neural organoids, warning that governance gaps reflect wider weaknesses in the ...

Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced ...

By spearheading AI-driven drug discovery, Lai and his company aim to make life-saving treatments more accessible. Lai is the ...

Biocon Executive Chairperson Kiran Mazumdar-Shaw speaks exclusively to Business Today TV in her first interview after announcing Claire Mazumdar as her successor. In this special conversation, Kiran ...

I am currently working on a project to improve the care of people living with rare diseases. Specifically, I’m leading a team ...

Konkani Nomenclature Vallak Sukhnyanchi’ blends ornithology and language to create a culturally rooted record of Goa’s rich ...

Polycystic ovary syndrome (PCOS), a condition affecting more than 170 million people worldwide, has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a landmark global ...

A new research report published today by Information Services Group (ISG) , a global AI-centered technology research and advisory firm, finds that aerospace and defense enterprises in Europe are ...

The Government has not confined its reform to the residential housing asset class. From 1 July 2027, the 50% CGT discount will be replaced by cost base indexation and a 30% minimum tax on real capital ...